Replies to post #22908 on Humanigen Inc (HGENQ)

[nelskof]

So, your changing the goal posts again? The primary outcome measure of the Lenzilumab trial is "Time to Recovery" for Covid-19. This has been the basis the FDA is awarding EUA. I have no doubt they will be approved.

Obviously, the data being shared with the DOD is significant enough to warrant CRADA & BARDA.